Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (DRKS00038045) titled 'Evaluation of Clinical Management and Outcome in High-Risk or Recurrent Endometrial Cancer' on Oct. 2.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: treatment
Primary Sponsor: AGO Research GmbH, AGO Studiengruppe
Condition:
C54.1
Malignant neoplasm: Endometrium
Intervention:
Group 1: The routine treatment and clinical outcomes of patients diagnosed with high-risk or recurrent endometrial cancer between 2023 and 2025 in gynecological cancer centers of the AGO study group will be recorded.
Recruitment Status: Not Recruiting
Date of First Enrollment: 31...